Skip to main content
SpringerLink
Log in

Toxic and Metabolic Disease

  • Chapter
Diffusion-Weighted MR Imaging of the Brain

  • 2389 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lexa FJ (1995) Drug-induced disorders of the central nervous system. Seminars in Roentgenol 30:7–17

    Google Scholar 

  2. Brown MS, Stemmer SM, Simon JH, et al. (1998) White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR Am J Neuroradiol 19:217–221

    PubMed  Google Scholar 

  3. Fujikawa A, Tsuchiya K, Katase S, Kurosaki Y, Hachiya J (2001) Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy. Eur Radiol 11:2602–2606

    Article  PubMed  Google Scholar 

  4. Tha KK, Terae S, Sugiura M, et al. (2002) Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta Neurol Scand 106:379–386

    Article  PubMed  Google Scholar 

  5. Matsumoto S, Nishizawa S, Murakami S, et al. (1995) Carmofur-induced leukoencephalopathy: MRI. Neuroradiology 37:649–652

    Article  PubMed  Google Scholar 

  6. Maschke M, Fehlings T, Kastrup O, Wilhelm HW, Leonhardt G (1999) Toxic leukoencephalopathy after intravenous consumption of heroin and cocaine with unexpected clinical recovery. J Neurol 246:850–851

    Article  PubMed  Google Scholar 

  7. Wolters EC, van Wijngaarden GK, Stam FC, et al (1982) Leucoencephalopathy after inhaling “heroin” pyrolysate. Lancet 2:1233–1237

    Article  PubMed  Google Scholar 

  8. Tan TP, Algra PR, Valk J, Wolters EC (1994) Toxic leukoencephalopathy after inhalation of poisoned heroin: MR findings. Am J Neuroradiol 15:175–178

    PubMed  Google Scholar 

  9. Chen CY, Lee KW, Lee CC, Chin SC, Chung HW, Zimmerman RA (2000) Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging. J Comput Assist Tomogr 24:735–737

    Article  PubMed  Google Scholar 

  10. Barnett MH, Miller LA, Reddel SW, Davies L (2001) Reversible delayed leukoencephalopathy following intravenous heroin overdose. J Clin Neurosci 8:165–167

    Article  PubMed  Google Scholar 

  11. Gocht A, Colmant HJ (1987) Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 6:262–270

    PubMed  Google Scholar 

  12. Sterns RH, Riggs JE, Schochet SS Jr (1986) Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314:1535–1542

    PubMed  Google Scholar 

  13. Ho VB, Fitz CR, Yoder CC, Geyer CA (1993) Resolving MR features in osmotic myelinolysis (central pontine and extrapontine myelinolysis. Am J Neuroradiol 14:163–167

    PubMed  Google Scholar 

  14. Norenberg MD (1983) A hypothesis of osmotic endothelial injury. A pathogenetic mechanism in central pontine myelinolysis. Arch Neurol 40:66–69

    PubMed  Google Scholar 

  15. Mascalchi M, Cincotta M, Piazzini M (1993) Case report: MRI demonstration of pontine and thalamic myelinolysis in a normonatremic alcoholic. Clin Radiol 47:137–138

    PubMed  Google Scholar 

  16. Rodriguez J, Benito-Leon J, Molina JA, Ramos A, Bermejo F (1998) Central pontine myelinolysis associated with cyclosporin in liver transplantation. Neurologia 13:437–440

    PubMed  Google Scholar 

  17. Miller RF, Harrison MJ, Hall-Craggs MA, Scaravilli F (1998) Central pontine myelinolysis in AIDS. Acta Neuropathol 96:537–540

    PubMed  Google Scholar 

  18. Cramer SC, Stegbauer KC, Schneider A, Mukai J, Maravilla KR (2001) Decreased diffusion in central pontine myelinolysis. AJNR Am J Neuroradiol 22:1476–1479

    PubMed  Google Scholar 

  19. Anderson AW, Zhong J, Petroff OA, et al (1996) Effects of osmotically driven cell volume changes on diffusion-weighted imaging of the rat optic nerve. Magn Reson Med 35:162–167

    PubMed  Google Scholar 

  20. Victor M,Adams RD, Collins GH (1971) The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 7:1–206

    PubMed  Google Scholar 

  21. Antunez E, Estruch R, Cardenal C, Nicolas JM, Fernandez-Sola J, Urbano-Marquez A (1998) Usefulness of CT and MR imaging in the diagnosis of acute Wernicke’s encephalopathy. AJR Am J Roentgenol 171:1131–1137

    PubMed  Google Scholar 

  22. Oka M, Terae S, Kobayashi R, et al. (2001) Diffusion-weighted MR findings in a reversible case of acute Wernicke encephalopathy. Acta Neurol Scand 104:178–181

    Article  PubMed  Google Scholar 

  23. Doherty MJ, Watson NF, Uchino K, Hallam DK, Cramer SC (2002) Diffusion abnormalities in patients with Wernicke encephalopathy. Neurology 58:655–657

    PubMed  Google Scholar 

  24. Chu K, Kang DW, Kim HJ, Lee YS, Park SH (2002) Diffusion-weighted imaging abnormalities in wernicke encephalopathy: reversible cytotoxic edema? Arch Neurol 59:123–127

    Article  PubMed  Google Scholar 

  25. Rugilo CA, Roca MC, Zurru MC, Gatto EM (2003) Diffusion abnormalities and Wernicke encephalopathy. Neurology 60:727–728; author reply 727–728

    Google Scholar 

  26. Gambini A, Falini A, Moiola L, Comi G, Scotti G (2003) Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study. Am J Neuroradiol 24:249–253

    PubMed  Google Scholar 

  27. Gass A, Birtsch G, Olster M, Schwartz A, Hennerici MG (1998) Marchiafava-Bignami disease: reversibility of neuroimaging abnormality. J Comput Assist Tomogr 22:503–504

    Article  PubMed  Google Scholar 

  28. Inagaki T, Saito K (2000) A case of Marchiafava-Bignami disease demonstrated by MR diffusion-weighted image. No To Shinkei 52:633–637

    PubMed  Google Scholar 

  29. Oppenheim C, Galanaud D, Samson Y, et al. (2000) Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 69:248–250

    Article  PubMed  Google Scholar 

  30. Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M (1999) Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 53: 2182–2184

    PubMed  Google Scholar 

  31. Yonemura K, Hasegawa Y, Kimura K, Minematsu K, Yamaguchi T (2001) Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. AJNR Am J Neuroradiol 22:269–272

    PubMed  Google Scholar 

  32. Ohshita T, Oka M, Imon Y, et al. (2000) Serial diffusion-weighted imaging in MELAS. Neuroradiology 42:651–656

    Article  PubMed  Google Scholar 

  33. Kim HS, Kim DI, Lee BI, et al. (2001) Diffusion-weighted image and MR spectroscopic analysis of a case of MELAS with repeated attacks. Yonsei Med J 42:128–133

    PubMed  Google Scholar 

  34. Majoie CB, Akkerman EM, Blank C, Barth PG, Poll-The BT, den Heeten GJ (2002) Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. AJNR Am J Neuroradiol 23:813–816

    PubMed  Google Scholar 

  35. Flemming K, Ulmer S, Duisberg B, Hahn A, Jansen O (2002) MR spectroscopic findings in a case of Alpers-Huttenlocher syndrome. AJNR Am J Neuroradiol 23:1421–1423

    PubMed  Google Scholar 

  36. Huttenlocher PR (2000) The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr Suppl 2:S102–S106

    Google Scholar 

  37. Pearsen KD, Gean-Marton AD, Levy HL, Davis KR (1990) Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology 177:437–440

    PubMed  Google Scholar 

  38. Phillips MD, McGraw P, Lowe MJ, Mathews VP, Hainline BE (2001) Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. AJNR Am J Neuroradiol 22:1583–1586

    PubMed  Google Scholar 

  39. Ono J, Harada K, Mano T, Sakurai K, Okada S (1997) Differentiation of dysand demyelination using diffusional anisotropy. Pediatr Neurol 16:63–66

    Article  PubMed  Google Scholar 

  40. Engelbrecht V, Scherer A, Rassek M, Witsack HJ, Modder U (2002) Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 222:410–418

    PubMed  Google Scholar 

  41. Sener RN (2003) Canavan disease: diffusion magnetic resonance imaging findings. J Comput Assist Tomogr 27:30–33

    PubMed  Google Scholar 

  42. Eichler FS, Itoh R, Barker PB, et al. (2002) Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 225:245–252

    PubMed  Google Scholar 

  43. Sener RN (2002) Metachromatic leukodystrophy: diffusion MR imaging findings. AJNR Am J Neuroradiol 23:1424–1426

    PubMed  Google Scholar 

  44. Sener RN (2003) L-2 hydroxyglutaric aciduria: proton magnetic resonance spectroscopy and diffusion magnetic resonance imaging findings. J Comput Assis Tomo 27:38–43

    Article  Google Scholar 

  45. Sener RN (2003) Diffusion magnetic resonance imaging in infantile neuroaxonal dystrophy. J Comput Assis Tomo 27:34–37

    Article  Google Scholar 

  46. Ellison D, Love S (1998) Toxic injury of the CNS. In: Neuropathology, 1st edn, section 8, chapter 25. Barcelona, Mosby, pp 25.1–25.22

    Google Scholar 

  47. Ono J, Harada K, Sakurai K, et al. (1994) MR diffusion imaging in Pelizaeus-Merzbacher disease. Brain Dev 16:219–223

    Article  PubMed  Google Scholar 

  48. Guo AC, Petrella JR, Kurtzberg J, Provenzale JM (2001) Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience. Radiology 218:809–815

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). Toxic and Metabolic Disease. In: Diffusion-Weighted MR Imaging of the Brain. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26386-1_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-26386-1_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25359-4

  • Online ISBN: 978-3-540-26386-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation